2:00 pm to 3:30 pm (ET) 6:00 pm to 7:30 pm (GMT)
Program # 094598
Director/Moderator: Jerry Holmberg, PhD, MT(ASCP)SBB, Senior Advisor for Blood Safety and Executive Secretary for the Advisory Committee on Blood Safety and Availability
Faculty: Commander Charles C.M. Lelkens, MD, Commanding Officer and Medical Director, Military Blood Bank, The Netherlands; Jeremy Perkins, MD, FACP, Chief, Hematology-Oncology Clinic, Walter Reed Army Medical Center
Intended Audience: Physicians, Scientists, Technologists, Nurses, Perfusionists
· Describe various limitations and barriers in the battlefield that may be similar to everyday practice in any community.
· Discuss massive transfusions in combat casualties including transfusion rates and mechanisms of injury.
· Recall the various component therapies that are often used in massive battlefield trauma cases and how strategies change based on clinical condition as well as available component therapy.
· Compare the indication, advantages, disadvantages and outcomes of various strategies to control bleeding and oxygen delivery in the battlefield trauma cases.
· Discuss outcomes in massive transfusion relating various ratios of components given such as FFP:RBC ratios and platelet:RBC ratios.
Event Description: Throughout history, the experiences and challenges of treating the wounded on the battlefield have been a stimulus for advances in medicine. The field of transfusion medicine and component therapy has been the recipient of much experience, much based on necessity in the battlefield. Data driven indications for use of fresh whole blood (FWB) in trauma are unknown. Currently there are no randomized trials comparing whole blood to component therapy in the setting of trauma. FWB use is limited in the U.S., although the military routinely utilizes FWB in the setting of massive transfusion as both a source of platelets and other factors when large quantities of blood are required. Drawing from battlefield experience, the speakers of this audioconference will discuss challenges and strategies used in the battlefield. Discussion will include the use of component therapy, whole blood, and frozen blood in controlling hemostasis and maintaining oxygen delivery to the tissues in the wounded military and civilian patients.
Event Level: Intermediate to Advanced